QTRam® for Content Uniformity Analysis of Low-Dose Pharmaceutical Tablets

Importance of the Topic

Content uniformity testing of low‐dose pharmaceutical tablets is critical for ensuring patient safety and dose accuracy. Regulatory guidelines such as USP <905> mandate individual tablet assay for products containing less than 25 mg or 25 % API by weight. Conventional techniques like HPLC and titration are destructive, time‐consuming, and generate solvent waste. In contrast, vibrational spectroscopy methods—particularly Transmission Raman Spectroscopy (TRS)—offer rapid, nondestructive, and reagent‐free measurements, enabling high‐throughput quality control.

Study Objectives and Overview

The study evaluates the performance of the QTRam® transmission Raman analyzer for quantifying low concentrations of acetaminophen in model tablets. A hypothetical formulation containing 0.5 % w/w APAP in a 300 mg tablet matrix was prepared in nine concentration levels. The primary aims are:

• To develop and validate a chemometric model for API quantification at sub‐percent levels.
• To demonstrate the speed, precision, and accuracy of QTRam for content uniformity.
• To establish detection and quantification limits for low‐dose tablets.

Methodology

Tablet blends comprised acetaminophen, mannitol, silicified microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. Nine formulations ranging from 0 % to 3 % APAP w/w were compressed into 10 mm diameter tablets (~300 mg). Transmission Raman spectra were collected with the following parameters:

• Sample interrogation area: 4 mm diameter.
• Spectral range: 200–1700 cm⁻¹.
• Acquisition: 10 scans averaged per spectrum, 3 s per scan.
• Replicates: Two to three spectra per tablet, eight tablets per blend.

Preprocessing steps for chemometric modeling included Savitzky–Golay first derivative, Standard Normal Variate (SNV) normalization, and mean centering. Partial Least Squares (PLS1) regression was applied to correlate Raman data with known APAP concentrations.

Used Instrumentation

The analytical setup consisted of:

• QTRam® Transmission Raman Spectrometer (BWT-840000893) by Metrohm/B&W Tek.
• STRaman® laser excitation and collection optics.
• BWAnalyst® software (21 CFR Part 11 compliant) for data acquisition and quantitative analysis.
• Embedded tablet computer interface for at‐line or laboratory use.

Main Results and Discussion

A survey calibration model using all nine blends yielded an RMSEC of 0.046 % APAP w/w with four latent variables. Focusing on blends up to 1.5 % improved performance: RMSEC of 0.022 % and RMSECV of 0.027 %. Validation on 0.5 % APAP tablets produced an RMSEP of 0.023 % and negligible bias (0.008 %). Calculated detection limit (LOD) was 0.074 % and quantification limit (LOQ) 0.23 % APAP w/w. Precision, expressed as standard deviation of six replicate measurements on a single tablet, was 0.016 % w/w. The model explained 94 % of spectral variance (X) and nearly 100 % of concentration variance (Y).

Benefits and Practical Applications

Transmission Raman analysis via QTRam® offers:

• Rapid, nondestructive content uniformity testing without sample preparation.
• High throughput and minimal operator intervention.
• Elimination of solvent waste and reduced per‐sample cost.
• Compliance with regulatory demands for low‐dose formulations.

Future Trends and Potential Applications

Advancements are expected in:

• Integration of inline TRS probes for real‐time process analytical technology (PAT) monitoring.
• Enhanced chemometric algorithms leveraging machine learning for improved robustness.
• Miniaturized, automated platforms for on‐site testing in manufacturing environments.
• Expansion to coated, multilayer, and complex solid dosage forms.

Conclusion

The QTRam® transmission Raman analyzer demonstrates fast, accurate, and precise quantification of low‐dose acetaminophen tablets, fulfilling regulatory requirements for content uniformity. Its nondestructive workflow and minimal consumable needs make it an attractive tool for pharmaceutical QC and PAT applications.

Reference

Metrohm AG. 7410000046-AQT Ram® for Content Uniformity Analysis of Low-Dose Pharmaceutical Tablets.